Incyte (INCY) EBIT Margin (2010 - 2026)

Incyte (INCY) reported EBIT Margin of 23.66% for Q1 2026, up 417.0% on a YoY basis from 4.58% in Q1 2025, and up 6.15% quarter-over-quarter from 22.29% in Q4 2025.

Incyte (INCY) EBIT Margin (2010 - 2026) Analysis & Trends

Incyte has reported EBIT Margin for 17 years, with the latest figure at 23.66% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin rose 417.0% year-over-year to 23.66%; the trailing twelve-month figure through Mar 2026 stood at 30.05% (up 2609.0% YoY), and the FY2025 full-year result was 29.46%, up 2802.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 23.66%, up from 22.29% in the prior quarter.
  • The five-year high for EBIT Margin was 43.63% in Q2 2025, with the low at 45.81% in Q2 2024.
  • Historically, EBIT Margin has averaged 16.35% across 5 years, with a median of 19.49% in 2025.
  • Annual changes were most pronounced in 2024 — EBIT Margin tumbled 6611 bps — and 2025, when it surged 8944 bps.
  • Incyte's EBIT Margin stood at 7.56% in 2022, then soared by 144 bps to 18.48% in 2023, then surged by 38 bps to 25.58% in 2024, then declined by 13 bps to 22.29% in 2025, then advanced by 6 bps to 23.66% in 2026.
  • The last three EBIT Margin figures came in at 23.66% (Q1 2026), 22.29% (Q4 2025), and 32.47% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 23.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.66%
Dec 31, 2025 22.29%
Sep 30, 2025 32.47%
Jun 30, 2025 43.63%
Mar 31, 2025 19.49%
Dec 31, 2024 25.58%
Sep 30, 2024 12.84%
Jun 30, 2024 -45.81%
Mar 31, 2024 10.43%
Dec 31, 2023 18.48%
Sep 30, 2023 23.36%
Jun 30, 2023 20.30%
Mar 31, 2023 3.06%
Dec 31, 2022 7.56%
Sep 30, 2022 16.81%
Jun 30, 2022 27.92%
Mar 31, 2022 15.89%
Dec 31, 2021 12.83%
Sep 30, 2021 28.96%
Jun 30, 2021 19.96%